News

When CRC is HER2+, dual HER2 inhibitor may beat standard EGFR inhibitors

Improving the TM proposal process with a consolidated, streamlined form

For every trial we open, SWOG takes steps to make enrollment as rapid and representative as possible

The PROSPECT-Lung trial opens just as Pragmatica-Lung is closing

Co-led by the Alliance and SWOG, CTIU2317 compares perioperative versus adjuvant systemic therapy in patients with resectable NSCLC